Holen Sie sich die Stockscreener-App
1.83
1.67%
0.03
Handel nachbörslich:
1.94
0.11
+6.01%
Schlusskurs vom Vortag:
$1.80
Offen:
$1.79
24-Stunden-Volumen:
28,647
Relative Volume:
2.09
Marktkapitalisierung:
$75.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.92M
KGV:
-6.10
EPS:
-0.3
Netto-Cashflow:
$-7.05M
1W Leistung:
+16.56%
1M Leistung:
+18.83%
6M Leistung:
+13.66%
1J Leistung:
-23.75%
1-Tages-Spanne:
$1.77
$1.96
1-Wochen-Bereich:
$1.53
$1.96
52-Wochen-Spanne:
$0.8001
$3.08
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Firmenname
Anebulo Pharmaceuticals Inc
Sektor
Branche
Telefon
737 203 5270
Adresse
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Vergleichen Sie ANEB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
1.83 | 64.50M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Anebulo Pharmaceuticals Inc Aktie (ANEB) Neueste Nachrichten
Anebulo Pharmaceuticals Inc. Stock Analysis and ForecastLightning-fast capital gains - jammulinksnews.com
What drives Anebulo Pharmaceuticals Inc. stock priceSuperior portfolio returns - jammulinksnews.com
What analysts say about Anebulo Pharmaceuticals Inc. stockDynamic profit opportunities - jammulinksnews.com
Is Anebulo Pharmaceuticals Inc. a good long term investmentRobust financial gains - jammulinksnews.com
Why Anebulo Pharmaceuticals Inc. stock attracts strong analyst attentionPredictable High Return Trades - Newser
Best Stocks for Small Investors in India AI Based Stock ScreeningDouble-digit growth - Autocar Professional
What drives Amgen Inc. stock priceFree Stock Movement Tracking - jammulinksnews.com
SOBR Stock Analysis and ForecastStrong return on assets - Jammu Links News
What makes Anebulo Pharmaceuticals Inc. stock price move sharplyMarket Trend Watch - Newser
What makes Wave Life Sciences Ltd. stock price move sharplyFree Stock Index Interpretation - Newser
How GFL Environmental Inc. stock performs during market volatilityVolume Spike Monitors - Newser
How Anebulo Pharmaceuticals Inc. stock performs during market volatilityMoney Making Low Risk Plans - Newser
Why Accretion Acquisition Corp. Equity Warrant stock attracts strong analyst attentionSafe and Smart Investment Picks - Newser
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Benchmark cuts Anebulo stock target to $3, keeps Speculative Buy By Investing.com - Investing.com Canada
Anebulo Pharmaceuticals (NASDAQ:ANEB) Is In A Good Position To Deliver On Growth Plans - simplywall.st
Benchmark cuts Anebulo stock target to $3, keeps Speculative Buy - Investing.com
Anebulo Pharmaceuticals (ANEB) Price Target Lowered by Maxim Gro - GuruFocus
Anebulo Pharmaceuticals (ANEB) Sees Price Target Reduced but Ret - GuruFocus
Anebulo Pharmaceuticals Focuses on Pediatric Cannabis Toxicity Treatment - TipRanks
Anebulo Pharmaceuticals (ANEB) Projected to Post Earnings on Wednesday - Defense World
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates - Business Wire
Head to Head Contrast: OnKure Therapeutics (NASDAQ:OKUR) & Anebulo Pharmaceuticals (NASDAQ:ANEB) - Defense World
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Large Increase in Short Interest - Defense World
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation - Yahoo
Anebulo Pharmaceuticals regains Nasdaq compliance By Investing.com - Investing.com India
Anebulo Pharmaceuticals regains Nasdaq compliance - Investing.com Australia
Anebulo Pharmaceuticals expands shares, restructures board - Investing.com Australia
Finanzdaten der Anebulo Pharmaceuticals Inc-Aktie (ANEB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):